Jody A. Charnow

Editor

Jody A. Charnow has been the editor of Renal & Urology News, a publication of Haymarket Media, since 2003. Previously, he had served as editor of Internal Medicine World Report and a managing editor for Medical Tribune. He holds a BA in biology from the State University of New York at Albany.

All articles by Jody A. Charnow

Diabetes

Nephropathy Progression in Type 1 Diabetes Linked to Depression

Jody A. Charnow

November 25, 2020

Whether successful treatment of depression reduces the risk for progression needs to be determined.

Diabetes

Apabetalone Prevents Post-ACS MACE Risk in Comorbid CKD, Diabetes

Jody A. Charnow

November 3, 2020

In the BETonMACE trial, CKD patients with type 2 diabetes who recently experienced acute coronary syndrome who received apabetalone had a significant 50% reduction in the risk for major cardiovascular events compared with placebo.

Diabetes

Finerenone Slows CKD Progression in Diabetic Kidney Disease

Jody A. Charnow

November 3, 2020

Finerenone vs placebo added to standard therapy was associated with a significant 18% reduction in the risk for major adverse kidney events in patients with both chronic kidney disease and type 2 diabetes mellitus.

Next post in Diabetes

Jody A. Charnow

All articles by Jody A. Charnow

Nephropathy Progression in Type 1 Diabetes Linked to Depression

Apabetalone Prevents Post-ACS MACE Risk in Comorbid CKD, Diabetes

Finerenone Slows CKD Progression in Diabetic Kidney Disease

Statins: No Effect on Diabetic Polyneuropathy Risk With Newly Diagnosed T2D